CBD Life Sciences Inc. (OTCMKTS:CBDL – Get Free Report) saw a large increase in short interest in the month of May. As of May 29th, there was short interest totaling 246,664 shares, an increase of ∞ from the May 14th total of 0 shares. Based on an average trading volume of 11,136,168 shares, the days-to-cover ratio is currently 0.0 days.
CBD Life Sciences Price Performance
Shares of OTCMKTS:CBDL opened at $0.00 on Friday. CBD Life Sciences has a 12-month low of $0.00 and a 12-month high of $0.00.
CBD Life Sciences Company Profile
CBD Life Sciences, Inc is a U.S.-based company focused on developing and commercializing cannabinoid‐enhanced products for the wellness and consumer healthcare markets. The company’s core strategy centers on leveraging plant-derived phytocannabinoids, along with complementary natural ingredients, to formulate a range of topical and ingestible offerings. CBD Life Sciences operates under an emerging‐brand model, seeking to position its products at the intersection of pharmaceutical‐grade quality and mainstream consumer appeal.
The company’s product portfolio includes broad‐spectrum hemp-derived topical creams, gels and balms designed for localized relief, as well as oral formulations such as capsules, tinctures and soft gels aimed at general wellness support.
Read More
- Five stocks we like better than CBD Life Sciences
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for CBD Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBD Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
